Table 1. Baseline characteristics of the study participants.
| Variables | ChAdOx1 (n=40) | BNT162b2 (n=36) | Total (n=76) | p-value | |
|---|---|---|---|---|---|
| Age (yr) | 40 (33–46) | 32 (26–36) | 35 (29–43) | <0.0001 | |
| Age group | <0.0001 | ||||
| 20s | 4 (10) | 16 (44) | 20 (26) | ||
| 30s | 14 (35) | 15 (42) | 29 (38) | ||
| 40s | 17 (43) | 4 (11) | 21 (28) | ||
| 50s | 4 (10) | 1 (2.8) | 5 (7) | ||
| 60s | 1 (3) | 0 (0) | 1 (1) | ||
| Sex | 1.000 | ||||
| Male | 16 (40) | 14 (39) | 30 (40) | ||
| Female | 24 (60) | 22 (61) | 46 (61) | ||
| Reactogenicity | |||||
| Local reaction | 5 (2–9) | 3 (0.25–5) | 3 (2–7) | 0.014 | |
| Systemic reaction | 12 (4–22) | 4.5 (0–13) | 7.5 (1–15) | 0.002 | |
| Total reaction | 18 (7–30) | 8 (1.3–17) | 12 (4–23) | 0.002 | |
Values are presented as median (interquartile range) or number (%).